Five Years of Ublituximab in Relapsing Multiple Sclerosis: Results from the Open-Label Extension of ULTIMATE I and II Studies

site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
vertical-expand: a:0:{}
caf_enhance: 0
Drug Category: Array
Conference Category: Array
Lead Author: Cree B. et al.
Published Date: 18/09/2025
Download Link: /wp-content/uploads/2024/09/Cree_P324_ECTRIMS_2024.pdf
Download Text:
Popup Confirmation?:
astra-migrate-meta-layouts: set
Scroll to Top